OHSU News

This email notification is intended as a heads up to OHSU communicators. It is not shared with external subscribers.

OHSU co-founded company, Autobahn Therapeutics, attracts $100 million investment

OHSU co-founded company, Autobahn Therapeutics, attracts $100 million investment

Massive investment advances treatment prospects for major depressive disorder, bipolar depression that affect tens of millions in U.S.